Abstract

Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension

Author(s): Davidson Michael G

Issue: Mar/Apr 2001 - Compounding for Animals

Page(s): 92-94

Download in electronic PDF format for $75
  • Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension Page 1
  • Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension Page 2
  • Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension Page 3

Abstract

The purpose of this article is to provide the compounding pharmacist with an overview of two ocular diseases that commonly affect cats and to describe the medications used in therapy. The author discusses feline herpesvirus-1 and systemic hypertension. A table provides selected drug therapies for feline conjunctivitis and keratitis, and a sidebar provides information regarding quinolone-induced blindness. In summary, four of the seven therapies for treating feline herpesvirus-related conjunctivitis and keratitis are commercially unavailable; and the therapy for feline hypertension is appropriate only for human dosing, so compounded dosage forms must often be used. Understanding ocular pharmacology and the underlying causes of feline ophthalmic disease can help the compounding pharmacist become integrally involved in feline care and can contribute to positive therapeutic outcomes and an increased quality of life for the patient.

Related Keywords

  • feline
  • keratitis
  • ophthalmic disease
  • systemic hypertension

Related Categories

  • VETERINARY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2001
Pg. 92-94
Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension
Author(s): Davidson Michael G
Nov/Dec 2010
Pg. 488-491
Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin
Author(s): Rudner Shara, Browne Paul
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Sep/Oct 2008
Pg. 392-397
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Author(s): Mixon William, Helms Scott R
Nov/Dec 2006
Pg. 411-414
Compounding for Feline Herpetic Keratitis
Author(s): Davidson Gigi S
May/Jun 2003
Pg. 188-191
Treating Canine Hepatic Disease
Author(s): Davidson Gigi S
May/Jun 2004
Pg. 169-172
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1
Author(s): Davidson Gigi S
Jan/Feb 2010
Pg. 40-45
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis
Author(s): Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
May/Jun 2012
Pg. 190-195
I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease
Author(s): McElhiney Linda F
Jan/Feb 2012
Pg. 34-41
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Author(s): Helms Scott R, Fox Samantha, Mixon William, Vail Jane
Jul/Aug 2016
Pg. 271-274
Compounding Transdermal Medication for Feline Patients
Author(s): Eichstadt Lauren R
Jan/Feb 2007
Pg. 44-48
Psychotropic Medications in the Treatment of Feline Urine Spraying
Author(s): Simpson Barbara Sherman, Vail Jane
Sep/Oct 2003
Pg. 345-347
Understanding Feline Hyperthyroidism
Author(s): Davidson Gigi S
Nov/Dec 2022
Pg. 468-472
Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Author(s): Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael
Jul/Aug 2004
Pg. 277-283
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2
Author(s): Davidson Gigi S
Sep/Oct 2004
Pg. 359-367
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 3
Author(s): Davidson Gigi S
Sep/Oct 2010
Pg. 421
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Author(s): Allen Loyd V Jr
Sep/Oct 2010
Pg. 382-394
Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists
Author(s): Meadows Richard L, Muller George
Mar/Apr 2010
Pg. 108-111
Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Author(s): Bramwell Bethany L
Sep/Oct 2016
Pg. 399-404
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Author(s): Allen Loyd V Jr